Karuna Therapeutics soars on potentially 'game changing' new schizophrenia drug

Karuna CEO Dr. Steve Paul and CNBC's Meg Tirrell discuss Karuna Therapeutics' new schizophrenia drug, which is said to be a 'game-changer.'

Power Lunch,CNBC,business news,finance stock,stock market,news channel,news station,breaking news,us news,world news,cable,cable news,finance news,money,money tips,financial news,stock market news,stocks,